Document Detail


Mechanisms of control of neuron survival by the endocannabinoid system.
MedLine Citation:
PMID:  18781978     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Endocannabinoids act as retrograde messengers that, by inhibiting neurotransmitter release via presynaptic CB(1) cannabinoid receptors, regulate the functionality of many synapses. In addition, the endocannabinoid system participates in the control of neuron survival. Thus, CB(1) receptor activation has been shown to protect neurons from acute brain injury as well as in neuroinflammatory conditions and neurodegenerative diseases. Nonetheless, some studies have reported that cannabinoids can also exert neurotoxic actions. Cannabinoid neuroprotective activity relies on the inhibition of glutamatergic neurotransmission and on other various mechanisms, and is supported by the observation that the brain overproduces endocannabinoids upon damage. Coupling of neuronal CB(1) receptors to cell survival routes such as the phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase pathways may contribute to cannabinoid neuroprotective action. These pro-survival signals occur, at least in part, by the cross-talk between CB(1) receptors and growth factor tyrosine kinase receptors. Besides promoting neuroprotection, a role for the endocannabinoid system in the control of neurogenesis from neural progenitors has been put forward. In addition, activation of CB(2) cannabinoid receptors on glial cells may also participate in neuroprotection by limiting the extent of neuroinflammation. Altogether, these findings support that endocannabinoids constitute a new family of lipid mediators that act as instructive signals in the control of neuron survival.
Authors:
Ismael Galve-Roperh; Tania Aguado; Javier Palazuelos; Manuel Guzmán
Related Documents :
20554448 - Synthesis and biodistribution of [11c]a-836339, a new potential radioligand for pet ima...
24513518 - Novel isonahocol e3 exhibits anti-inflammatory and anti-angiogenic effects in endotheli...
23423278 - Ion-based materials of boron-modified dipyrrolyldiketones as anion receptors.
19079598 - Modulation of network oscillatory activity and gabaergic synaptic transmission by cb1 c...
6313258 - Hormone receptors in dystrophic and neoplastic vulvar disease. preliminary considerations.
2345768 - N-modified fluorophenyltropane analogs of cocaine with high affinity for cocaine recept...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current pharmaceutical design     Volume:  14     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2008  
Date Detail:
Created Date:  2008-09-10     Completed Date:  2008-11-17     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  2279-88     Citation Subset:  IM    
Affiliation:
Department of Biochemistry and Molecular Biology I, School of Biology, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Complutense University, 28040 Madrid, Spain. igr@quim.ucm.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Survival / physiology
Endocannabinoids / metabolism*
Humans
Neurodegenerative Diseases / physiopathology
Neuroglia / metabolism
Neurons / metabolism*
Receptor Protein-Tyrosine Kinases / metabolism
Receptor, Cannabinoid, CB1 / metabolism*
Signal Transduction*
Chemical
Reg. No./Substance:
0/Endocannabinoids; 0/Receptor, Cannabinoid, CB1; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CNS immune surveillance and neuroinflammation: endocannabinoids keep control.
Next Document:  Expression and function of the endocannabinoid system in glial cells.